Insomnia in women

Clinical Cornerstone

Volumn 5, Issue 3, 2003, Pages 41-50

  Krystal, Andrew D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BUSPIRONE; DIPHENHYDRAMINE; ESTROGEN; HYPNOTIC SEDATIVE AGENT; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; ZOLPIDEM;

ANXIETY DISORDER; BEHAVIOR THERAPY; CLIMACTERIUM; CLINICAL PRACTICE; CLINICAL STUDY; COGNITIVE THERAPY; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTITIONER; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; INSOMNIA; LEISURE; LUTEAL PHASE; MAJOR DEPRESSION; MEDICAL LITERATURE; MEDICAL RESEARCH; MENOPAUSE; MENSTRUAL CYCLE; PATIENT CARE; PATIENT EDUCATION; PHYSICAL CAPACITY; POLYSOMNOGRAPHY; PRACTICE GUIDELINE; PREGNANCY; PREMENSTRUAL DYSPHORIC DISORDER; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SAFETY; SEX DIFFERENCE;

EID: 0242551973     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(03)90034-2     Document Type: Article

References (30)

1. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, fourth Edition. Washington, DC: American Psychiatric Association; 1994.
2. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999;22 (Suppl 2):S347-S353.
3. Ohayon MM, Roth T. What are the contributing factors for insomnia in the general population? J Psychosom Res. 2001;51:745-755.
4. Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care patients. Sleep. 1999; 22(Suppl 2):S359-S365.
5. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep. 1999;22(Suppl 2):S386-S393.
6. Zammit GK, Weiner J, Damato N, et al. Quality of life in people with insomnia. Sleep. 1999;22(Suppl 2):S379-S385.
7. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. II. Sleep. 1999;22(Suppl 2):S354-S358.
8. American Sleep Disorders Association (ASDA). The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. Rochester, Minn: American Sleep Disorders Association; 1997.
9. Baker A, Simpson S, Dawson D. Sleep disruption and mood changes associated with menopause. J Psychosom Res. 1997;43:359-369.
10. Mauri M. Sleep and the reproductive cycle: A review. Health Care Women Int. 1990;11:409-421.
11. Krystal AD, Edinger J, Wohlgemuth W, Marsh GR. Sleep in peri-menopausal and post-menopausal women. Sleep Med Rev. 1998;2:243-253.
12. Lancel M, Faulhaber J, Holsboer F, Rupprecht R. Progesterone induces changes in sleep comparable to those of agonistic GABA A receptor modulators. Am.J Physiol. 1996;271(4 Pt 1):E763-E772.
13. Eichling PS. Evaluating and treating menopausal sleep problems. Menopause Manage. 2002; September/October:8-16.
14. Santiago JR, Nolledo MS, Kinzler W, Santiago TV. Sleep and sleep disorders in pregnancy. Ann Intern Med. 2001;6:396-408.
15. Manber R, Bootzin RR. Sleep and the menstrual cycle. Health Psychol. 1997;16:209-214.
16. Lee KA, Shaver JF, Giblin EC, Woods NF. Sleep patterns related to menstrual cycle phase and premenstrual affective symptoms. Sleep. 1990;13:403-409.
17. Parry BL, Mostofi N, LeVeau B, et al. Sleep EEG studies during early and late partial sleep deprivation in premenstrual dysphoric disorder and normal control subjects. Psychiatry Res. 1999;85:127-143.
18. American Sleep Disorders Association (ASDA). Practice parameters for the use of polysomnography in the evaluation of insomnia. Sleep. 1995;18:55-57.
19. Pearlstein T, Joliat MJ, Brown EB, Miner CM. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment. Am J Obstet Gynecol. 2003; 188:887-895.
20. Asnis GM, Chakraburtty A, DuBoff EA, et al. Zolpidem for persistent insomnia in SSRI-treated patients. J Clin Psychiatry. 1999;60:668-676.
21. Von Muhlen DG, Kritz-Silverstein D, Barrett-Connor E . A community-based study of menopause symptoms and estrogen replacement in older women. Maturitas. 1995;22:71-78.
22. Edinger JD, Wohlgemuth WK, Radtke R, et al. Cognitive behavioral therapy for treatment of chronic primary insomnia: A randomized controlled trial. JAMA. 2001;285:1856-1864.
23. Pansini F, Albertazzi P, Bonaccorsi G. Trazodone: A non-hormonal alternative for neurovegetative climacteric symptoms. Clin Exp Obstet Gynecol. 1995;22:341-344.
24. Nowell PD, Mazumdar S, Buysse DJ, et al. Benzodiazepines and zolpidem for chronic insomnia: A meta-analysis of treatment efficacy. JAMA. 1997;278:2170-2177.
25. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262: 1479-1484.
26. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39:411-418.
27. Londborg PD, Smith WT, Glaudin V, Painter JR. Short-term cotherapy with clonazepam and fluoxetine: Anxiety, sleep disturbance and core symptoms of depression. J Affect Disord. 2000;61:73-79.
28. Thase ME. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry. 1999;60(Suppl 17):28-31.
29. Nierenberg AA, Adler LA, Peselow E, et al. Trazodone for antidepressant-associated insomnia. Am J Psychiatry. 1994;151:1069-1072.
30. Scharf MB, Sachais BA. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J Clin Psychiatry. 1990;51(Suppl):13-17.